| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 17, 2010Interventional Cardiology Meeting Features New Data on Resolute(R) Drug-Eluting Stent, IN.PACT(TM) Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve
MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease,Medtronic, Inc. (NYSE: MDT), today...
-
Sep 16, 2010Further Clinical Study Required for Application to U.S. Food and Drug Administration
MINNEAPOLIS, Sep 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain...
-
Sep 14, 2010
MINNEAPOLIS, Sep 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the UBS Global Life Sciences...
-
Sep 13, 2010System Supports Proactive Patient Care for Patients at Risk for Worsening Heart Failure
MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced the CareLink(R) Network for Heart Failure, an extension of the world's largest remote implantable cardiac...
-
Sep 13, 2010Medical Device Leader Recognized for Corporate Sustainability
MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...